Page last updated: 2024-10-24

carmustine and Peritoneal Neoplasms

carmustine has been researched along with Peritoneal Neoplasms in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiorillo, A1
Maggi, G1
Martone, A1
Migliorati, R1
D'Amore, R1
Alfieri, E1
Greco, N1
Cirillo, S1
Marano, I1
Lokich, JJ1
Brooks, JR1

Other Studies

2 other studies available for carmustine and Peritoneal Neoplasms

ArticleYear
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
    Journal of neuro-oncology, 2001, Volume: 52, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combi

2001
Disappearance of disseminated pancreatic carcinoma with combined chemotherapy.
    Annals of surgery, 1973, Volume: 177, Issue:1

    Topics: Adult; Carcinoma, Intraductal, Noninfiltrating; Carmustine; Duodenum; Fluorouracil; Gastrectomy; Hum

1973